Bayer CropScience invests EUR 12 million in expansion of Nunhems research facilities in the Netherlands
Bayer CropScience’s vegetable seed business Nunhems will invest EUR 12 million in the expansion and modernization of its research center in the municipality of Leudal, the Netherlands. The existing research building will be enlarged from 2,200 square meters to a total size of 6,400 square meters and will be equipped with state-of-the-art laboratories for Nunhems’ Biotech services like DNA analyses as well as for Seed Technology, Cell Biology and Molecular Breeding. The extended and modernized research facilities are scheduled to be fully operational by the end of 2011.
Dr. Joachim Schneider, Head of BioScience at Bayer CropScience, considers the investment a further step in the strategic expansion of the business: “By upgrading our research facilities, we will be in an even better position to develop innovative vegetable seed varieties with good yields, disease resistance and excellent quality.”
“Technology is moving fast and has become a competitive component in vegetable breeding,” commented Dr. Johan Peleman, Nunhems’ Managing Director of Research and Development. Nunhems follows an “Integrated Breeding” approach, where technology is an integral part of the breeding activities. Next to the Netherlands, Nunhems has research centers in Bangalore (India) and Davis, California (USA).
Most read news
Organizations
Other news from the department business & finance
These products might interest you

Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation

Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Ablynx Demonstrates Proof-of-Concept by Biomarker For Its Anti-Thrombotic ALX-0081
Xenon Enters Into Anemia Collaboration With Roche - Xenon to Receive $7 Million for Equity, and Could Potentially Receive $44 Million From Research Funding and Milestone Payments
OGT Awarded ISO/IEC 17025:2005 Accreditation
A vaccine alternative protects mice against malaria - Vectored immunoprophylaxis injection triggers creation of antibodies that prevent malaria in 70 percent of mice

Images from the inside of blood vessels - Smallest 3D printed miniature endoscope in the world detects cholesterol plaques and thrombs inside human and mouse arteries

How To Draw Electricity from the Bloodstream - A one-dimensional fluidic nanogenerator with a high power-conversion efficiency
